Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Jianxing He

Clinical trials sponsored by Jianxing He, explained in plain language.

Trials to join now! 1 Not yet recruiting 3 Completed 2

New combo targets tough lung cancer mutation before surgery

Disease control Recruiting now

This study tests a new treatment plan for people with a specific type of lung cancer (KRAS G12C mutation) that can be removed with surgery. Before surgery, patients receive a targeted drug (fulzerasib) for 6 weeks, then a break, followed by 3 cycles of immunotherapy (sintilimab) …

Phase: PHASE2 • Sponsor: Jianxing He • Aim: Disease control

Last updated May 26, 2026 06:45 UTC